Editors-in-Chief
Aimée Dudley
Aimée Dudley, Ph.D., is a Senior Investigator and Interim Chief Scientific Officer at the Pacific Northwest Research Institute. She earned her B.S. in biochemistry and molecular biology from the University of Massachusetts at Amherst and her Ph.D. in genetics from Harvard Medical School. Dr. Dudley was an Alexander Hollaender Distinguished Postdoctoral Fellow in Dr. George Church’s laboratory at Harvard Medical School. In addition to her roles at PNRI, Dr. Dudley co-chairs the Washington Research Foundation’s Postdoctoral Fellowship Selection Committee and is a scientific advisor to FenoLogica Biosciences, a scientific instrumentation company founded on technology developed in her lab. In her previous role as PNRI’s Director of Educational Outreach, she partnered with community groups to bring high school and undergraduate students from underrepresented communities to PNRI to explore science as a career. She also mentors graduate students through her affiliate appointment in the University of Washington’s Department of Genome Sciences, and as a faculty member in the Molecular Engineering Graduate Program and the Molecular and Cellular Biology Graduate Program.
Anne Goriely
Anne Goriely, PhD, is a molecular geneticist who is currently Professor of Human Genetics at the MRC Weatherall Institute of Molecular Medicine (WIMM), Radcliffe Department of Medicine (RDM), University of Oxford.
After an undergraduate degree in Engineering (Agronomy) at the Université Libre de Bruxelles (Belgium), Anne Goriely obtained a PhD studying the development of the nervous system of the Drosophila embryo. She spent 4 years in New York at Cornell Medical School and Rockefeller University (with Dr Claude Desplan), before moving to the UK to work on the nervous system development of the chick embryo. She then joined the MRC WIMM to study the origin of rare human developmental disorders associated with paternal age effects.
Using a human genetics approach, her group’s main interests lie in elucidating the mechanisms by which we acquire new germline mutations and the implications of such processes in health and disease. She is currently the Equality Diversity and Inclusion (EDI) Academic Lead for her department, the Radcliffe Department of Medicine and has a special interest in finding effective strategies to improve research culture and assist, particularly women and minority groups, in realising their full leadership potential.